Ipratropium bromide nasal solution (nasal spray), 0.03% gives symptomatic relief in cases associated with allergic and ...
Grasim Industries, the flagship entity of the Aditya Birla Group, posted a consolidated net loss of ₹ 168.7 crore for Q3 FY25 ...
Mumbai: Global pharma major Lupin Limited has announced that it has received approval from the United States Food and Drug ...
Shares of Lupin Ltd dropped 2.8% despite a significant Q3 profit increase of 38.8% year-on-year. The company's revenue surged ...
Stocks including Eicher Motors, Lupin, MTAR Technologies, Aditya Birla Capital, Nykaa, Bata india, SBFC Finance, Samhi Hotels ...
The Indian stock market is set for an eventful session today, with Gift Nifty opening at 23,485.5 and currently trading 0.06% ...
Shares of Vodafone Idea, SAIL, IRCTC, Tata Investment and Ircon will be in focus as the companies will announce their third ...
Lupin Receives Approval from U. S. FDA for Ipratropium Bromide Nasal Solution (NASAL Spray) 0.03% Lupin and Natco Receive Approval from U. S. FDA for Bosentan Tablets for Oral Suspension. Intimation ...
Lupin Receives Approval from U. S. FDA for Ipratropium Bromide Nasal Solution (NASAL Spray), 0.03% ...
The trial will evaluate the safety and effectiveness of a next-generation vaccine administered through a nasal spray or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback